How many institutional investors hold MDWD?

4 tracked institutional investors disclosed a position in MDWD (MEDIWOUND LTD) in their most recent 13F filing.

Who is the largest institutional holder of MDWD?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in MDWD, valued at $3M.

Where does this MDWD ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

MDWD — MEDIWOUND LTD

Name: MEDIWOUND LTD (MDWD) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About MEDIWOUND LTD (MDWD)

MEDIWOUND LTD (MDWD) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $3M. Across recent filings, tracked investors recorded 1 new positions, 2 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in MDWD

100

/100

Strong Institutional Accumulation

Added / Increased3

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track MDWD

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

MDWD Ownership Composition

How MEDIWOUND LTD is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

37% of tracked value

Institutions

tracked investors

Total Reported

$7.8M

combined 13F value

Other36.6%
Hedge Funds36.4%
Growth Funds27.0%

Other(2)

36.6%

Hedge Funds(1)

36.4%

Growth Funds(1)

27.0%

Tracked investors reporting MDWD

Investor	Firm	Shares	Market value	% of portfolio	As of
Steve Cohen	Point72 Asset Management	175.5K	$2.8M	0.00%	Mar 31, 2026
Cathie Wood	ARK Investment Management	130K	$2.1M	0.02%	Mar 31, 2026
Izzy Englander	Millennium Management	102.1K	$1.9M	0.00%	Dec 31, 2025
Ken Griffin	Citadel Advisors	59.2K	$954.4K	0.00%	Mar 31, 2026

Steve CohenMar 31, 2026
Point72 Asset Management
Shares
175.5K
Value
$2.8M
% Portfolio
0.00%
Cathie WoodMar 31, 2026
ARK Investment Management
Shares
130K
Value
$2.1M
% Portfolio
0.02%
Izzy EnglanderDec 31, 2025
Millennium Management
Shares
102.1K
Value
$1.9M
% Portfolio
0.00%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
59.2K
Value
$954.4K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Cathie Wood	Increased	22.15%	$2.1M	May 12, 2026
Cathie Wood	Increased	9.82%	$2M	Feb 11, 2026
Cathie Wood	New	—	$1.7M	Nov 12, 2025

Cathie Wood
Increased
$2.1M(22.15%)May 12, 2026
Cathie Wood
Increased
$2M(9.82%)Feb 11, 2026
Cathie Wood
New
$1.7MNov 12, 2025

Frequently asked questions

How many institutional investors hold MDWD?: 4 tracked institutional investors disclosed a position in MDWD (MEDIWOUND LTD) in their most recent 13F filing.
Who is the largest institutional holder of MDWD?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in MDWD, valued at $3M.
Did institutional ownership of MDWD increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 2 increased, 0 reduced, and 0 fully exited MDWD.
Where does this MDWD ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.